跳至主要内容
临床试验/NCT02209038
NCT02209038已完成不适用

A Randomized Trial of Expanded Choice Sets to Increase Completion of Advance Directives

University of Pennsylvania29 个研究点 分布在 1 个国家目标入组 321 人开始时间: 2014年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
321
试验地点
29
主要终点
advance directive

研究概览

简要总结

There is a large gap between the care seriously ill patients want and the care they receive. Advance directives (ADs) offer an opportunity for patients to express specific end-of-life preferences to avoid unwanted care. As promising as ADs may be for improving the quality of care near the end of life, rates of AD completion remain low and previous efforts to encourage their completion have had limited success. Principles of behavioral economics, such as the effects of defaults and other framing effects, may offer a novel approach to bridge the gap in end-of-life care. The goal of this study is to test whether the framing effect of expanding choice sets can increase the completion of and specification of choices within advance directives.

详细描述

This study has been designed as two sequential randomized trials to test two separate expanded choice set interventions, with the second randomization enrollment being contingent on results from the first. All enrolled subjects will be asked if they would like to complete an advance directive and will have been randomized to receive either an expanded answer choice set or a standard answer choice, as described in detail elsewhere. Only those subjects who express a desire to complete an advance directive from both arms will then be randomized again in a stratified fashion to receive either a standard advance directive or one with an expanded choice set for the decisions regarding life-sustaining therapy, as described in detail elsewhere.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older
  • Proficient in English
  • Chronic hemodialysis for minimum 90 days
  • Does not currently have a living will

排除标准

  • Blindness
  • Cognitive impairment that prohibits subject's provision of informed consent

结局指标

主要结局

advance directive

时间窗: up to 4 weeks

return of a completed and signed advance directive

次要结局

  • Medical Outcomes Study Short Form-12v2(baseline and 3 months)
  • no life-sustaining therapy preference specified(up to 4 weeks)
  • McGill Quality of Life Questionnaire(baseline and 3 months)
  • Satisfaction with Decision Scale(baseline)
  • Decisional Conflict Scale(up to 4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验